Paragangliomas da Cabeça e Pescoço: A Experiência de um Centro Oncológico do Sul da Europa
DOI:
https://doi.org/10.20344/amp.17185Keywords:
Carotid Body Tumor, Cranial Nerve Neoplasms, Extra-Adrenal Paraganglioma, Head and Neck Neoplasms, ParagangliomaAbstract
Introduction: Paragangliomas are usually benign slow-growing tumors, but they are locally invasive and can cause significant morbidity. The aim of this study was to characterize the presenting symptoms, secretory status, genetics, imaging features, treatment modalities, post-treatment complications and survival of patients with head and neck paragangliomas treated at a single institution.
Material and Methods: We retrospectively reviewed the clinical records of patients managed at our center between 1997 and 2020.
Results: Seventy-three patients were included in the study, encompassing 89 head and neck paragangliomas. Forty-eight patients (65.8%) were female and 15 (20.5%) had multiple tumor sites (including 10 patients with multicentric benign paragangliomas and five with disseminated malignant disease). Regarding location, our series encompassed 40 temporal bone paragangliomas (44.9%), 24 carotid body paragangliomas (27%), 22 vagal paragangliomas (24.7%), two laryngeal paragangliomas (2.2%) and one sinonasal paraganglioma (1.1%). Excessive catecholamine secretion was detected in 11 patients (15.1%). Sixty-four patients (87.7%) underwent genetic testing. Of those, 24 (37.5%) exhibited pathogenic succinate dehydrogenase complex germline mutations. Regarding patients who presented with untreated disease, 45 patients (66.2%), encompassing 55 tumors, underwent surgery as primary treatment modality, 20 (29.4%; 23 tumors) were initially treated with radiotherapy and three patients (4.4%, encompassing three solitary tumors) were kept solely under watchful waiting. Five-year overall survival was 94.9% and disease-free survival was 31.9%.
Conclusion: Head and neck paragangliomas are rare, slow-growing but locally aggressive tumors resulting in high morbidity but low mortality rates.
Downloads
References
Sivalingam S, Shin SH, Lella FD, Lauda L, Sanna M. Tympanojugular paragangliomas. In: Kirtane MV, Souza CE, editors. Otology and
neurotology. Stuttgart: Thieme; 2013. Chapter 34.
Sanna M, Piazza P, Shin SH, Flanagan S, Mancini F. Microsurgery of skull base paragangliomas. Stuttgart: Thieme; 2013. DOI: https://doi.org/10.1055/b-0034-65638
Prasad SC, Paties CT, Pantalone MR, Mariani-Constantini R, Sanna M. Carotid body and vagal paragangliomas: epidemiology, genetics, clinicopathological features, imaging, and surgical management. In: Mariani-Costantini R, editor. Paragangliomas: a multidisciplinary approach. Brisbane; Codon Publications; 2019. Chapter 5. DOI: https://doi.org/10.15586/paraganglioma.2019.ch5
Prasad SC, Paties CT, Schiavi F, Esposito DL, Lotti LV, Mariani-Costantini R, et al. Tympanojugular paragangliomas: surgical
management and clinicopathological features. In: Mariani-Costantini R, editor. Paragangliomas: a multidisciplinary approach. Brisbane; Codon Publications; 2019. Chapter 6.
Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94:730-7. DOI: https://doi.org/10.1002/cncr.10252
Badenhop RF, Jansen JC, Fagan PA, Lord RS, Wang ZG, Foster WJ, et al. The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. J Med Genet. 2004;41:e99. DOI: https://doi.org/10.1136/jmg.2003.011551
Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617–22. DOI: https://doi.org/10.1136/jmg.39.9.617
Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017;11:278-87. DOI: https://doi.org/10.1007/s12105-017-0803-4
Martins R, Bugalho MJ. Paragangliomas/pheochromocytomas: clinically oriented genetic testing. Int J Endocrinol. 2014;2014:794187. DOI: https://doi.org/10.1155/2014/794187
Gupta N, Strome SE, Hatten KM. Is routine genetic testing warranted in head and neck paragangliomas? Laryngoscope. 2019;129:1491-3. DOI: https://doi.org/10.1002/lary.27656
Majewska A, Budny B, Ziemnicka K, Ruchała M, Wierzbicka M. Head and neck paragangliomas - a genetic overview. Int J Mol Sci. 2020;21:7669. DOI: https://doi.org/10.3390/ijms21207669
Valero C, Ganly I, Shah JP. Head and neck paragangliomas: 30-year experience. Head Neck. 2020;42:2486-95. DOI: https://doi.org/10.1002/hed.26277
González-Orús Álvarez-Morujo RJ, Arístegui Ruiz MÁ, da Costa Belisario J, Martinez Guirado T, Scola Yurrita B. Head and neck paragangliomas: experience in 126 patients with 162 tumours. Acta Otorrinolaringol Esp. 2015;66:332-41. DOI: https://doi.org/10.1016/j.otoeng.2014.11.004
Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and neck paragangliomas: an update on evaluation and Mmanagement. Otolaryngol Head Neck Surg. 2016;154:597-605. DOI: https://doi.org/10.1177/0194599815627667
Sanna M, Fois P, Pasanisi E, Russo A, Bacciu A. Middle ear and mastoid glomus tumors (glomus tympanicum): an algorithm for the surgical management. Auris Nasus Larynx. 2010;37:661-8. DOI: https://doi.org/10.1016/j.anl.2010.03.006
Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Herrera-Gomez A. Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification. Eur Arch Otorhinolaryngol. 2006;263:171-5. Erratum in: Eur Arch Otorhinolaryngol. 2006;263:1161. DOI: https://doi.org/10.1007/s00405-005-0968-4
Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME. Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg. 1998;124:1133-40. DOI: https://doi.org/10.1001/archotol.124.10.1133
House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93:146-7. DOI: https://doi.org/10.1177/019459988509300202
Cass ND, Schopper MA, Lubin JA, Fishbein L, Gubbels SP. The changing paradigm of head and neck paragangliomas: what every Otolaryngologist needs to know. Ann Otol Rhinol Laryngol. 2020;129:1135-43. DOI: https://doi.org/10.1177/0003489420931540
Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, et al. Benign paragangliomas: clinical presentation
and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001;86:5210-6. DOI: https://doi.org/10.1210/jcem.86.11.8034
Liu P, Li M, Guan X, Yu A, Xiao Q, Wang C, et al. Clinical syndromes and genetic screening strategies of pheochromocytoma and paraganglioma. J Kidney Cancer VHL. 2018;5:14-22. DOI: https://doi.org/10.15586/jkcvhl.2018.113
Opocher G, Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010;24:943- DOI: https://doi.org/10.1016/j.beem.2010.05.001
Lenders JW, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1443-56. DOI: https://doi.org/10.1097/HJH.0000000000002438
Álvarez-Morujo RJ, Ruiz MÁ, Serafini DP, Delgado IL, Friedlander E, Yurrita BS. Management of multicentric paragangliomas: review of 24 patients with 60 tumors. Head Neck. 2016;38:267-76. DOI: https://doi.org/10.1002/hed.23894
Rijken JA, de Vos B, van Hest LP, Dreijerink KM, den Heijer M, Wisselink W, et al. Evolving management strategies in head and neck
paragangliomas: a single-centre experience with 147 patients over a 60-year period. Clin Otolaryngol. 2019;44:836-41. DOI: https://doi.org/10.1111/coa.13380
Prasad SC, Sanna M. The role of radiation in tympanojugular paragangliomas needs to be objectively re-evaluated. Otol Neurotol.
;38:1060-2.
Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28:17–8. DOI: https://doi.org/10.1002/stem.261
Cama A, Verginelli F, Lotti LV, Napolitano F, Morgano A, D’Orazio A, et al. Integrative genetic, epigenetic and pathological analysis of
paraganglioma reveals complex dysregulation of NOTCH signaling. Acta Neuropathol. 2013;126:575–94. DOI: https://doi.org/10.1007/s00401-013-1165-y
Lin J, Liu C, Gao F, Mitchel RE, Zhao L, Yang Y, et al. miR-200c enhances radiosensitivity of human breast cancer cells. J Cellular
Biochem. 2013;114:606-15. DOI: https://doi.org/10.1002/jcb.24398
Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 2013;23:12–9. DOI: https://doi.org/10.1016/j.gde.2013.01.002
Maki Y, Asano H, Toyooka S, Soh J, Kubo T, Katsui K, et al. MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells. Anticancer Res. 2012;32:4871–5.
Sen C, Hague K, Kacchara R, Jenkins A, Das S, Catalano P. Jugular foramen: microscopic anatomic features and implications for neural preservation with reference to glomus tumors involving the temporal bone. Neurosurgery. 2001;48:838–47. discussion 847 – 8. DOI: https://doi.org/10.1227/00006123-200104000-00029
Spector GJ, Fierstein J, Ogura JH. A comparison of therapeutic modalities of glomus tumors in the temporal bone. Laryngoscope.
;86:690–6.
Handel SF, Miller MH, Miller LS, Goepfert H, Wallace S. Angiographic changes of head and neck chemodectomas following radiotherapy. Arch Otolaryngol. 1977;103:87–9. DOI: https://doi.org/10.1001/archotol.1977.00780190067006
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Acta Médica Portuguesa - Ordem dos Médicos
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
